News | May 25, 2022
Max Healthcare Institute Q4 FY2022 consolidated PAT slips QoQ to Rs. 123.73 Cr
The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022
The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients
Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
Includes thermostabilized Ebola vaccines
A total of five observations for Goa and 17 for Monroe
Investment with representation on the Board of Directors and technical know-how
Subscribe To Our Newsletter & Stay Updated
